Parexel (PRXL) plummeted 18% AH after it reported FQ3 earnings below estimates and cut its...

|By:, SA News Editor

Parexel (PRXL) plummeted 18% AH after it reported FQ3 earnings below estimates and cut its profit and revenue forecasts for fiscal 2011. EPS was +23% to $0.26 and revenue +3% to $301.4M. The pharma research firm plans to restructure in response. (PR)